Perthera AI

Excited to be at and wanted to share some news about Perthera AI. If you're in Chicago this weekend, stop by booth #26116 and say hello. We have lots to share!

At ASCO '23, AI Precision Oncology Company Perthera Unveils Premium Experience for Clinicians with New Options for Ordering and Access to Enhanced Perthera Analytics /PRNewswire/ -- ASCO 2023 – McCormick Place, In advance of a new Current Procedural Terminology (CPT) Category III code that will go into effect on July 1st,...

The Perthera AI Clinical Team is proud to to support the Colorectal Cancer Alliance in its mission to end colorectal cancer.

Did you know that In 2023, an estimated 153,020 people will be diagnosed with this highly preventable disease? They will join more than 1.4 million colorectal cancer patients and survivors living today. We go blue for them, their families, and their community.

is a wrap and we are thrilled to have so many people stop by the booth to learn more about our new AI Analytics platform. Now available to Centers across the country:

PERTHERA AI ANALYTICS LAUNCHES IMPROVED ANALYTICS, CLINICAL TRIAL OPTIMIZATION AND PATIENT CARE MANAGEMENT TOOL AT ASCO Perthera AI’s proven data mining, analytics, optimization and care management platform now available for cancer centers to utilize for their own data analysis.

The FDA approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies.

FDA approves second CAR-T cancer therapy to treat multiple myeloma, opening the door for greater access The FDA has approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies.